THALOMID REMS Trademark

Trademark Overview

On Wednesday, April 3, 2013, a trademark application was filed for THALOMID REMS with the United States Patent and Trademark Office. The USPTO has given the THALOMID REMS trademark a serial number of 85894152. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 12, 2024. This trademark is owned by Celgene Corporation. The THALOMID REMS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Programs in the nature of providing medical counseling and medical information in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical counseling and medical information in the field of thalidomide and safety issues pertaining to thalidomide, and providing medical information in the aforementioned fields by distributing written materials in connection therewith
thalomid rems

General Information

Serial Number85894152
Word MarkTHALOMID REMS
Filing DateWednesday, April 3, 2013
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 12, 2024
Registration Number4439517
Registration DateTuesday, November 26, 2013
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 10, 2013

Trademark Statements

Description of MarkThe mark consists of "THALOMID" in black letters and "REMS" in red.
Indication of Colors claimedThe color(s) black and red is/are claimed as a feature of the mark.
Goods and ServicesPrograms in the nature of providing medical counseling and medical information in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical counseling and medical information in the field of thalidomide and safety issues pertaining to thalidomide, and providing medical information in the aforementioned fields by distributing written materials in connection therewith
Disclaimer with Predetermined Text"REMS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 9, 2013
Primary Code044
First Use Anywhere DateFriday, January 11, 2013
First Use In Commerce DateFriday, January 11, 2013

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Tuesday, March 12, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, March 12, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 12, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 12, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 3, 2023TEAS SECTION 8 & 9 RECEIVED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, November 26, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, December 20, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 20, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, December 20, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 26, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, November 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 26, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 10, 2013PUBLISHED FOR OPPOSITION
Wednesday, August 21, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 7, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 2, 2013ASSIGNED TO LIE
Friday, July 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 19, 2013EXAMINER'S AMENDMENT ENTERED
Friday, July 19, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2013EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, July 19, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2013NON-FINAL ACTION E-MAILED
Friday, July 19, 2013NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2013ASSIGNED TO EXAMINER
Tuesday, April 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 6, 2013NEW APPLICATION ENTERED

Related Keywords

rems thalomid medical providing information written distributing fields materials connection therewith aforementioned